Uganda Approves the Lenacapavir Injectable HIV Prevention Drug Kampala, January 2026 Uganda’s National Drug Authority (NDA) has approved Lenacapavir, a long‑acting injectable medicine for preventive use, as part of the country’s comprehensive HIV prevention strategy. This decision represents a major milestone in expanding prevention options for individuals at high risk of HIV infection and accelerates…